Drug companies that commit to moving production to the U.S. will face a 20% tariff and no tariff if they also agree to lower prices.
  • Bwaz@lemmy.worldEnglish
    9·
    6 days ago

    Cue big increases in drug insurance prices and in percentage of people who can’t afford needed medicines. Just another tax on those who have no say – taxation without representation like days of yore.